These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23911669)

  • 1. Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
    Queiroz-Junior CM; Bessoni RL; Costa VV; Souza DG; Teixeira MM; Silva TA
    Life Sci; 2013 Sep; 93(9-11):423-8. PubMed ID: 23911669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral Microbiota.
    Queiroz-Junior CM; Madeira MF; Coelho FM; Costa VV; Bessoni RL; Sousa LF; Garlet GP; Souza Dda G; Teixeira MM; Silva TA
    J Immunol; 2011 Oct; 187(7):3821-30. PubMed ID: 21890656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental arthritis exacerbates Aggregatibacter actinomycetemcomitans-induced periodontitis in mice.
    Queiroz-Junior CM; Madeira MF; Coelho FM; de Oliveira CR; Cândido LC; Garlet GP; Teixeira MM; de Souza Dda G; Silva TA
    J Clin Periodontol; 2012 Jul; 39(7):608-16. PubMed ID: 22582749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats.
    Lima V; Vidal FD; Rocha FA; Brito GA; Ribeiro RA
    J Periodontol; 2004 Jan; 75(1):162-8. PubMed ID: 15025228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.
    Queiroz-Junior CM; Silveira KD; de Oliveira CR; Moura AP; Madeira MF; Soriani FM; Ferreira AJ; Fukada SY; Teixeira MM; Souza DG; da Silva TA
    J Periodontal Res; 2015 Dec; 50(6):814-23. PubMed ID: 25753377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis.
    Oliveira MC; Tavares LP; Vago JP; Batista NV; Queiroz-Junior CM; Vieira AT; Menezes GB; Sousa LP; van de Loo FA; Teixeira MM; Amaral FA; Ferreira AV
    PLoS One; 2016; 11(1):e0146403. PubMed ID: 26742100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation.
    Fonseca LC; Dadarkar SS; Lobo AS; Suthar AC; Chauhan VS; Chandrababu S; Sharma SD; Dagia NM; Padigaru M
    Eur J Pharmacol; 2010 Oct; 644(1-3):220-9. PubMed ID: 20621086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats.
    Quinteiro MS; Napimoga MH; Mesquita KP; Clemente-Napimoga JT
    Eur J Pain; 2012 Sep; 16(8):1106-15. PubMed ID: 22354681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.
    Silveira KD; Coelho FM; Vieira AT; Barroso LC; Queiroz-Junior CM; Costa VV; Sousa LF; Oliveira ML; Bader M; Silva TA; Santos RA; Silva AC; Teixeira MM
    Peptides; 2013 Aug; 46():53-63. PubMed ID: 23727291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis.
    Roth A; Mollenhauer J; Wagner A; Fuhrmann R; Straub A; Venbrocks RA; Petrow P; Bräuer R; Schubert H; Ozegowski J; Peschel G; Müller PJ; Kinne RW
    Arthritis Res Ther; 2005; 7(3):R677-86. PubMed ID: 15899053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.
    Nissler K; Pohlers D; Hückel M; Simon J; Bräuer R; Kinne RW
    Ann Rheum Dis; 2004 Nov; 63(11):1470-7. PubMed ID: 15479897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis.
    Oliveira PG; Grespan R; Pinto LG; Meurer L; Brenol JC; Roesler R; Schwartsmann G; Cunha FQ; Xavier RM
    Arthritis Rheum; 2011 Oct; 63(10):2956-65. PubMed ID: 21953084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
    Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C; Ribeiro AC; Fabri GM; Calich AL; Carvalho J; Silva CA; Viana VS; Bonfá E; Siqueira JT
    J Clin Rheumatol; 2012 Jun; 18(4):180-4. PubMed ID: 22647860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
    Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
    Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.